{
  "id": 2454643,
  "title": "Vertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?",
  "url": "https://urgent.news/2026/08/21/vertex-pharmaceuticals-a-biotech-cash-cow-with-pipeline-upside",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-21T23:20:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/vertex-pharmaceuticals-biotech-cash-cow-pipeline-upside"
  },
  "original_language": "en",
  "account": null,
  "summary": "Explore the exciting world of Vertex Pharmaceuticals (NASDAQ: VRTX) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Vertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?",
        "url": "https://urgent.news/2026/08/21/vertex-pharmaceuticals-a-biotech-cash-cow-with-pipeline-upside-2460027",
        "published": "2026-08-21T23:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}